Russell Investments Group, Ltd. Maravai Lifesciences Holdings, Inc. Transaction History

Russell Investments Group, Ltd.

$84.2 Billion
Q3 2025

A detailed history of Russell Investments Group, Ltd. transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 112,307 shares of MRVI stock, worth $408,797. This represents 0.0% of its overall portfolio holdings.

Number of Shares

112,307

Previous 40,346 178.36%

Holding current value

$408,797

Previous $97,000 231.96%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$2.03 - $2.89 $146,080 - $207,967	71,961 Added 178.36%	112,307 $322,000
Q2 2025 Aug 13, 2025	SELL	$1.72 - $2.47 $522 - $750	-304 Reduced 0.75%	40,346 $97,000
Q1 2025 May 13, 2025	BUY	$2.21 - $6.13 $89,836 - $249,184	40,650 New	40,650 $89,000
Q2 2024 Aug 08, 2024	SELL	$6.87 - $11.34 $79,719 - $131,589	-11,604 Reduced 88.04%	1,577 $11,000
Q1 2024 May 08, 2024	SELL	$5.11 - $8.76 $508,010 - $870,875	-99,415 Reduced 88.29%	13,181 $114,000

Q4 2023 Feb 05, 2024	BUY	$4.7 - $9.87 $528,359 - $1.11 Million	112,417 Added 62802.79%	112,596 $737,000
Q3 2023 Nov 13, 2023	BUY	$9.14 - $12.85 $1,398 - $1,966	153 Added 588.46%	179 $1,000
Q2 2023 Aug 10, 2023	SELL	$12.09 - $15.0 $33,852 - $42,000	-2,800 Reduced 99.08%	26 $0
Q1 2023 May 09, 2023	SELL	$12.99 - $16.48 $272,257 - $345,404	-20,959 Reduced 88.12%	2,826 $39,000
Q4 2022 Feb 08, 2023	BUY	$12.5 - $24.78 $297,312 - $589,392	23,785 New	23,785 $340,000

Others Institutions Holding MRVI

# of Institutions

182

Shares Held

132M

Call Options Held

688K

Put Options Held

11.6K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $479M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Maravai Lifesciences Holdings, Inc. Transaction History